Company profile

Attomarker company profile

Attomarker is a spin-out company from the University of Exeter, a member of the UK’s Russell Group of research-intensive universities. The company’s founder, Professor Andrew Shaw, leads a team of scientists and engineers across the UK & Germany. Backed by six patents and referenced in 17 academic journals, Attomarker works. Realising the vision that has inspired many, but has, until now, proved so hard to turn into reality. Patented Attomarker technology collects the blood on a disposable credit-card sized chip which slots into a mobile pocket-sized devise, docked to an iPhone. The camera visualises the blood tests which are then..... For more information, log in to dureach.com to view the full company profile.

Business identity

Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2008-01-01

Headquarters

Headquarters
Exeter, England, United Kingdom
Postal code
EX4 4QD
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$4M
Last funding
Convertible Note / 2020-06-01
Last equity funding
Series A / $3.3M
Investors
2
Founders
1
Articles
5

Founders and investors

Founders

Prof. Andrew Shaw

Investors

Future Planet CapitalThe British Innovation Fund

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.